Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03365739 · ClinicalTrials.gov registry record · NA
Bioavailability and Pharmacokinetics of Mango
A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03365739: Completed NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
NCT03365739 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03365739, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The primary objectives of the study are: 1. To investigate the relative bioavailability and absorption/kinetic profile of phytochemicals after acute consumption of mango pulp. 2. To study the systemic accumulation or generation of new mango pulp phytochemicals /their metabolites in blood after regular mango intake for an extended time frame. 3. To enhance the bioavailability of polyphenols in mango pulp by addition of Vitamin C to the mango pulp.
Primary Outcome
This will be conducted by using ultra-high performance liquid chromatography iFunnel quadrupole time of flight mass spectrometer (UHPLC-QTOF-MS) and triple quadrupole mass spectrometer (UHPLC-QQQ-MS).
Interventions
- DIETARY_SUPPLEMENT Active Comparator 1
- DIETARY_SUPPLEMENT Active Comparator 2
- DIETARY_SUPPLEMENT Control Comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-11-17 |
| Est. Completion | 2020-05-31 |
| Phase | NA |
What the finished NCT03365739 record still lists
NCT03365739 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Active Comparator 1 is the first listed.
NCT03365739 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03365739 about?
NCT03365739 is a clinical study titled "Bioavailability and Pharmacokinetics of Mango". The primary objectives of the study are: 1. To investigate the relative bioavailability and absorption/kinetic profile of phytochemicals after acute consumption of mango pulp. 2. To study the systemic accumulation or generation of new mango pulp phytochemicals /their metabolites in blood after regu...
What is the current status of trial NCT03365739?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-11-17. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT03365739?
The interventions under investigation include: Active Comparator 1 (DIETARY_SUPPLEMENT), Active Comparator 2 (DIETARY_SUPPLEMENT), Control Comparator (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03365739?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03365739's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI